Delivery Order SPE2DB20D3103-SPE2DB25FQ2J4
- Not listed
- The Defense Logistics Agency awarded a $19,295.10 delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/ml, a biologic medication used primarily to treat rheumatoid arthritis and other autoimmune conditions. This competitively awarded, firm fixed-price contract with no set-aside designation was executed on September 3, 2025, with an ultimate completion date of September 4, 2025, indicating expedited fulfillment requirements. The product will be delivered to Conshohocken,...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Orencia ClickJect 125 mg/mL, a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions. This non-competitive delivery order, valued at $3,954.49 with firm fixed pricing, is scheduled for completion by August 5, 2025, and will be fulfilled from the contractor's Conshohocken, Pennsylvania facility. The award represents a...
- The Defense Logistics Agency awarded a $76,256.03 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Orencia ClickJect 125 mg/ml, a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions. The award was made on August 5, 2025, with an ultimate completion date of August 6, 2025, and the product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was issued on a...
- The Defense Logistics Agency awarded a delivery order valued at $23,618.84 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a biologic medication used to treat autoimmune conditions. This firm fixed-price delivery order, issued on August 21, 2025, with an ultimate completion date of August 22, 2025, represents a non-competitive, non-set-aside award. The place of performance is listed as Conshohocken, Pennsylvania, which is AmerisourceBergen's corporate headquarters location....
- The Defense Logistics Agency awarded a $17,050.91 firm fixed price delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. The contract was competitively awarded with no set-aside designation and has an ultimate completion date of September 11, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a $28,511.98 delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. The contract, awarded on August 11, 2025, with completion targeted for August 12, 2025, utilized firm fixed pricing with no set-aside designation, indicating competitive award to the qualified vendor. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a $13,069.86 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Orencia Clickject 125 mg/mL, a biologic medication used primarily for rheumatoid arthritis treatment. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 9, 2025, with performance to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $83,196.81 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. This firm fixed-price delivery order, awarded on August 11, 2025, represents a non-set-aside competitive award and is expected to reach completion by August 12, 2025. The place of performance is located at AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a delivery order valued at $9,964.08 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. This firm fixed-price delivery order, issued on August 14, 2025, represents a non-set-aside competitive award with an ultimate completion date of August 15, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $39,105.45 firm fixed price delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. The award, issued on August 18, 2025, with an ultimate completion date of August 19, 2025, represents a non-competitive delivery order under a larger contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is one...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FQ2J4Delivery Order
The Defense Logistics Agency awarded a $21,369.30 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Orencia ClickJect 125 mg/mL, a biologic medication used to treat autoimmune conditions such as rheumatoid arthritis. This firm fixed-price delivery order, with an ultimate completion date of September 11, 2025, represents a non-set-aside competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The point of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical distributor serving federal medical procurement needs. This award falls under AmerisourceBergen's comprehensive $999,999,999.00 indefinite delivery vehicle designated SPE2DX with DLA Troop Support Medical, which extends through December 2026 and authorizes the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare systems globally. The pharmaceutical distributor holds a significant position within the Defense Health Agency's medical supply chain and has demonstrated consistent capability to fulfill federal requirements through competitive procurement processes across multiple therapeutic domains and customer bases including the Department of Defense and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.4k | 9/10/25 |